Try our Advanced Search for more refined results
Life Sciences - May, 2021
327 articles
- Law360 Names 2021's Top Attorneys Under 40
- 10X Infringes Bio-Rad Patents, Federal Circuit Affirms
- Key Opioid Trials To Watch As Cases Heat Up Nationwide
- Kodak Suit Over Exec Stock Options, $765M Loan Sent To NY
- Fed. Circ. Reverses PTAB, Axes Baxter Telepharmacy Patent
- Elizabeth Holmes Wants 45-Page Questionnaire For Jurors
- Biden Science Adviser Approved By Senate
- GOP Introduces Bill That Would Ban Federal Vaccine Passport
- Eli Lilly Gets More Time To Respond To HHS Letter
- J&J Unit Must Face Warning Claims Over Neutrogena Wipes
- Venture Firm Can't Escape OvaScience IVF Suit, Judge Says
- Miss. Secretary Of State Won't Fight Ruling Nixing Medical Pot
- FDA Opts To Keep Unapproved Drug Program Axed By Trump
- Goodwin Steers Biotech Holding Firm's Upsized $330M IPO
- DEA Opens The Door To Pot Research. Is Legalization Next?
- 5 Tips To Help Your 2021 Summer Associates Succeed
- Illumina, Grail Say FTC Just Wants To Run Out Merger Clock
- JPML Weighs New Opioid MDL As McKinsey Suits Surge
- 3rd Circ. Says NJ Cap Doesn't Block Mesh Case Fees In Texas
- IP Forecast: Cell Giants To Defend Wireless Tech In EDTX
- Fla. High Court Upholds State's Medical Marijuana Framework
- Judge Questions Bid To Move Acthar Cases To Delaware
- Bayer May End Glyphosate Retail US Sales
- Tricida Directors Hit With Securities Suit Over Drug Approval
- Panel Hears 3 Venue Options For Crop Inputs MDL
- 5 Current Ad And Marketing Legal Risks To Watch Out For
- EU, AstraZeneca Spar Over Vaccine Delivery Deadlines
- It's Time For States To Enact Effective Marijuana DUI Laws
- Ex-Gilead Workers Hit Back With Sanctions Bid In FCA Fight
- Latham-Led Health Apparel Co. Leads 3 IPOs Totaling $964M
- Firms Should Use Surveys To Make Smart Legal Tech Choices
- Purdue Statement Gives Creditors Enough Info, Judge Says
- Suit Presses EPA To Enforce Air Pollution Standards
- Fla. Men Latest Charged For Bogus COVID Health Care Bills
- DOJ Nominee On Track As GOP Blasts 'Defense Judges'
- Startup Says Digital Health Co. Lied About Acquisition
- Mallinckrodt Ch. 11 Trustee Hearing Set For Confirmation
- Dems Start Quest For Centerpiece Of Biden's Health Agenda
- Chubb Unit Gets Dismissal Of Health System's $5M Virus Suit
- University Nurse's Negligence Wasn't 'State-Created Danger'
- McKool Smith Snags NY-Based IP Pair From King & Spalding
- Insurance Ruling Clarifies Excess Coverage For Opioid Suits
- Messner Reeves Adds Ex-Ropers Majeski Litigation Squad
- Okla. AG To Resign Amid Reports Of Extramarital Affair
- Judge Won't OK $2B Deal For Future Roundup Claims
- 3rd Circ. Backs Legal Funder In Contract Breach Appeal
- DOJ Wants Time During SmileDirect's Calif. Dental Board Args
- Actavis Inks $1.1M Deal In ADHD Medication Antitrust Suit
- Judge Revisits Grocer's Defense Dispute Over Opioid Injury
- IP Waiver Talks Hinge On Use Of Big Pharma's Trade Secrets
- Feds Fight Bid For High Court Review Of FCA Standard
- 8th Circ. Won't Revive Mentor Breast Implant Suit
- AMAG Escapes Suit Over Preterm Birth Drug's Effectiveness
- There Is No 'Junk Science' Epidemic In Consumer Litigation
- Don't Forget Due Diligence In Race For Lateral Associate Hires
- UK Regulator Will Scrutinize AstraZeneca-Alexion Deal
- Burns Scalo GC On The Hunger For Life Sciences Real Estate
- New Circuit Split Complicates Domestic Securities Test
- Former Trump HHS Counsel Rejoins Greenberg Traurig
- Coronavirus Regulations: A State-By-State Week In Review
- CBD Co. Seeks To Dodge Sanctions Bids In IP Row
- Senate Approves Manatt Phelps Vet For Top HHS Post
- Calif. Jury Hears Of Heartbreak In Case Of Destroyed Embryos
- Needles Litter Oakland, City Official Says In Opioid Trial
- Watchdog Backs DOD's Use Of Contentious $1B COVID Fund
- Cannabis Entrepreneurs' Family Fighting Spills Into Court
- DEA Can't Ban Psilocybin Therapy, States Tell 9th Circ.
- Purdue's New Ch. 11 Plan Docs Detail Claims Trust Framework
- MiMedx Not A Victim, Can't Get $40M Restitution In Fraud Suit
- Hagens Berman Loses Privilege In Thalidomide Sanction Fight
- Eli Lilly Says HHS Trying To Foil Case Over Drug Discounts
- Jury Can Hear Some Evidence Of Elizabeth Holmes' Wealth
- Gilead Gets PTAB To Wipe Out University's Antiviral IP Claims
- Drug Co. Says Emory Prof Backing False Probiotic Claims
- US, Claims Rep Challenge Mallinckrodt Ch. 11 Disclosures
- Ariosa, Illumina Resolve DNA Patent Dispute At High Court
- Addressing Environmental Justice As Part Of ESG Initiatives
- Trial Icon Hanly Remembered As Litigator's Litigator
- NJ Justices Won't Reconsider Ducking Fray Over Mesh Fees
- Justices Won't Hear Cancer Research Patent Fight
- 4th Circ. Halts Block On SC Horseshoe Crab Harvests
- Endo Investors Win Operatic Class Cert. In Generic Price Suit
- Claims Court Wants VA Medical Supply Deal Transfer Stopped
- Investor Brings Class Suit Over Surprise Diabetes Drug Delay
- Drugmakers Throw Purdue Under Bus In Opioid Trial Gamble
- Pharma Orgs Lay Out Vaccine Access Plan Without IP Waiver
- Shkreli, Vyera Rip FTC Sanction Bid Over Alleged Phone Wipe
- G-20 Health Accord Shows Split On Waiving COVID IP
- Pot Co. Harvest Wants Out Of Fight Over Arkansas Facility
- Midcase Appeal In Opioid Bellwether Not Needed, Tribe Says
- ITC To Probe Apple Watches In Portable EKG Patent Row
- Once Sizzling IPO Market Starts To Show Cracks
- Drug Industry Group Slams Mallinckrodt Ch. 11 Disclosures
- HIV Drug IP Waiver Success Should Guide COVID Vax Rollout
- GOP Lawmakers Look To Bar Visas For IP Thieves, Spies
- Health Hires: Freshfields, DLA Piper, Cozen O'Connor
- Lessons In Civility From The Alex Oh Sanctions Controversy
- Indian Drugmaker Morepen Nabs $100M From Corinth Group
- UK Litigation Roundup: Here's What You Missed In London
- IP Forecast: Customer Service Secrets Row Heads To Jury
- Industry Tells 9th Circ. No Cancer Warning For Glyphosate
- FTC To Focus On In-House Challenge Of Illumina Deal
- Canadian Hemp Co. Can't Escape US Contract, 6th Circ. Told
- Cigna Defeats Class Cert. Bid In ERISA Suit Over Drug Prices
- Ex-Insys CEO Escapes FCA Suit Over Opioid Bribes, For Now
- Dove 'Stain Defense' Lets Them See You Sweat, Suit Says
- Ill. Justices Side With Columbia Care Unit In Pot Grow Fight
- US, Global Tax Revamp Could Fill Vaccine Need, Study Says
- A Practical Metric For Annual Patent Filing Targets: Part 1
- Navigating Development Bank COVID-19 Relief Probes
- EPA Sued For Delay In Evaluating PVC As Hazardous Waste
- FTC Tells Justices To Nix Sham Litigation Exception Case
- Trade Groups Urge Justices To Review $600M NY Opioid Tax
- Mallinckrodt's Ch. 11 Claim Deadline OK'd Over Opposition
- Biz Record Admissibility Rule Must Adapt To An ESI World
- Cooley Adds Ex-Nelson Mullins IP, Life Sciences Pro In Boston
- Purdue Says It May Have To Push Back Ch. 11 Schedule
- Paper Mill Co-Owned By Robert Kraft Sued Over Air Pollution
- 5th Circ. Revives Conspiracy Case Against Quest Diagnostics
- Judge Raises Litigation Risks, Doubts In $2B Roundup Deal
- House Again Passes Bill To Reform Orphan Drug Exclusivity
- Biz Groups Back PBMs In North Dakota Preemption Fight
- Tilray Says Fla. Grower's Suit Is 'Improper' And 'Absurd'
- Merck Settles With UFCW Unit In Retroactive OT Suit
- Akin Gump Beefs Up In DC With Addition Of Ex-FDA Official
- Hikma Urges Justices To Skip Case On Obviousness Evidence
- Sens. Pitch Bill To Regulate CBD Products In Food And Drink
- Lessons From COVID Securities Rulings On Dismissal Bids
- Overlooked Patent Cases: Preclusion's Effect On Settlement
- GOP Sens. Bash COVID IP Waiver As 'Giveaway' To China
- What Attorneys Should Know About State MDLs
- Hagens Berman Suffers Privilege Defeat In Thalidomide Row
- Biogen Asks Justices To Review Pfizer's MS Drug Win
- 11th Circ. Hints Pharma Co.'s Fight With Gov't Mooted
- FTC Wants Shkreli Sanctioned For Allegedly Wiping Phone
- Ex-Doc Gets 59 Years For Unnecessary Surgeries, $21M Fraud
- Takeda Unit Inks Deal To End IP Suit After Bayer's $173M Win
- Paul Weiss Attys To Guide Roe V. Wade Defense At High Court
- US Chamber Backs Walmart In 5th Circ. Opioid Challenge
- CDC Pushed Tasks To White Colleagues, Ex-Worker Says
- Dems Call For FTC Probe Into AbbVie's Humira Deals
- Health Plans Win Class Cert. In CVS Price-Gouging Suit
- Feds' Oversight Found Lacking On Energy-Saving Deal
- Inside The Dispute Over $2B Deal For Future Roundup Claims
- Gilead Wants Harsher Sanctions For Kickbacks Whistleblower
- Colo. Laws Can't Make It Harder To Prove Medical Pot Defense
- Terms Of $2.8B Genomic Sale Shield Deal, Chancery Told
- Arent Fox Chases Pharmaceutical Co. For Unpaid Legal Fees
- Opening Args In NY Opioid Trial Set For End Of June
- $8M Asbestos Win Stands In Secondhand Exposure Death Suit
- Med Buyers Say Mallinckrodt Too Incompetent To Run Ch. 11
- DOJ, HHS Watchdog Warn Vaccines Must Be Free
- Missouri Pot Regulators Can't Keep Applications Secret
- Boston Marriott Hits Insurer For Limiting Virus Coverage
- BD Building $202M Manufacturing Facility In Spain
- Justices Must Weigh Class Cert. Denial Stats In Goldman Case
- Courts Are Aligning Patent Fraud, Inequitable Conduct Claims
- Aggregating Claimant And Case Data In Mass Torts
- Coronavirus Regulations: A State-By-State Week In Review
- Judging A Book: Rodriguez Reviews 'When Machines Can Be Judge'
- With Roe's Future In Doubt, Here's How The Justices May Rule
- FTC Takes Disgorgement Off Table In Surescripts Case
- Kodak Says NY Has Threatened To File Insider Trading Suit
- Utah Appellate Court Won't Redo Pot Licensing Decision
- Real Estate Rumors: Longfellow, Gomez, CVS
- Novartis Can't Claw Back Atty Email In Terbutaline Drug Suit
- Shkreli Cos.' Ability To Pay Penalties Irrelevant, FTC Says
- Alabama Legalizes Medical Pot With Restrictive Law
- Cooley Lands In Chicago With 10-Partner Team
- Imerys Seeks Permission To Pursue Ch. 11 Acquisitions
- High Court Won't Review Enbrel Patent Ruling
- FTC Continues Crackdown On CBD Sellers' Cure-All Claims
- 11th Circ. Won't Rethink Revival Of Lab Trustee's $31M Suit
- High Court Won't Hear $70M Risperdal Verdict Challenge
- Justices To Weigh Abortion Case That Could Upend Roe
- DEA Opens Up Pot Research With Scientist Agreements
- 9th Circ. Won't Wipe Out $25M Roundup Verdict
- Buyers Win Cert. In Ranbaxy Generic-Drug Antitrust Case
- USPTO Will Expedite Appeals, Oppositions For Virus TM Apps
- AGs Say High Court Ruling Doesn't Weaken Drug Price Claims
- Eye Care Chain MyEyeDr. Hit With TCPA Suit
- 9th Circ. Says EPA Must Revisit Lead-Related Standards
- HHS Defends Medicare Drug Program Cuts At High Court
- Ecolab Inks $2.5M OT Deal With Dozens Of Workers
- Let's End The Offshoring Of US Patents
- Minn. House OKs Legalizing, Taxing Recreational Marijuana
- Brand Battles: Crips LLC Faces TM Fight Over Name
- Fla. Appellate Court Tosses Investors From $17M Pot Co. Suit
- EU Medical Device Regulation May Spur Litigation Uptick
- How Early Data Analysis Can Inform FCA Litigation Strategy
- Health Hires: Sheppard Mullin, Galecto, LogicBio
- Miss. High Court Overturns Medical Pot Ballot Measure
- Cooley-Led Biotech Prices IPO Low As More Companies Delay
- Philips Slaps MRI Repair 'Hacker' With Trade Secret Suit
- Philly Judge OKs Investors' $4M CBD Study Settlement Deal
- 5 Steps For Law Firms Rethinking Flexible Work Post-COVID
- PBMs Aren't Ready To Throw In Towel In Preemption Fight
- Vaxart Investors Can Tweak Stock Claims Over COVID Vaccine
- Okla. Says Pot's Federal Illegality Dooms Residency Challenge
- Indivior Wants Ex-Worker's Retaliation Claims Thrown Out
- Groups Tell 11th Circ. To Flip Roundup Cancer Link Ruling
- IP Forecast: Cox Case To Restart Patent Jury Trials In Del.
- Kirkland, Ellenoff Guide Biotech SPAC's $200M IPO
- Life Sciences Real Estate Boom May Outlast Logistics Rush
- UCB Can't Halt Drug Ingredient Import In Vimpat IP Case
- COVID IP Waiver Doesn't Resolve Vaccine Production Barriers
- Moderna's Appeal Based On 'Imagined' Error, Fed. Circ. Told
- Life Sciences Software Biz Axtria Lands $150M In Funding
- Attys 'Wasting Time' In Sluggish Opioid Trial: Calif. Judge
- UNC Prof. Testifies That Stem Cell Clinic's Treatment Is Safe
- Medical Device Co. Sues Over Ex-Worker's Move To Medtronic
- Judge Halts Crab Harvest In SC Wildlife Refuge
- AdventHealth Wins $1.5M From PPE Fraud Settlement Default
- Challenging Class Cert. When Plaintiffs Missed 'False' Ad
- Tai Clashes With Senators Over COVID-19 Vaccine IP Waiver
- 2nd Circ. Won't Revive Suit Against Pfizer Over Lipitor
- Rosen Law Will Lead Walmart Investor Suit In Delaware
- 5 Firms Guide CD&R's £2.6B Bet On UDG
- Purdue's Ch. 11 Confirmation Hearing Set For August
- Judge's Rebuke Of Mass. AG Has Lessons For All Attorneys
- Walmart Wants 5th Circ. To Revive Opioid Suit Against Feds
- Hartford Wants Out From Ill. Toxic Emissions Suit Coverage
- FDA Investigator Says Stem Cell Clinic Lacked Documentation
- Elizabeth Holmes' Mystique Unlikely To Survive Looming Trial
- Senate Confirms Andrea Palm As HHS Deputy Secretary
- Tesaro Directors Slam 'Innuendo' In Del. Suit Over $5.1B Sale
- Fed. Circ. Backs Oxford Nanopore's DNA Tech IP Trial Victory
- Wife Cannot Sue Spouse's Co. Over Her COVID-19 Infection
- 3M's Expert Nixed From Earplug MDL Bellwether Case
- Dem Commissioner Blasts 'Pro-Merger' Pharma Stance At FTC
- AbbVie Slapped With Suit From Would-Be Humira Rival
- Texas Pharma Co. Settles Opioid Whistleblower Suit For $2.8M
- COVID IP Waiver Still Has Doubters In Europe, Industry
- Coronavirus Regulations: A State-By-State Week In Review
- USPTO Grants US Patent No. 11,000,000
- Insulin Pump Maker Says Roche Sneaked Into Market
- Font Considerations To Give Your Legal Briefs An Edge
- Ginkgo Bioworks Valued At $15B In SPAC Deal Led By 3 Firms
- 1st Circ. Agrees Ex-Tech Firm Execs 'Instrumental' In Scheme
- UMiami Pays $22M To Settle Medicare Overbilling FCA Suit
- GSK Gets Fines Slashed In UK Pay-For-Delay Case
- Natera Cancer Test Infringes Invitae Patent, Suit Alleges
- Aqua Pennsylvania Hits Slew Of Chem Cos. With PFAS Suit
- Westco Chemicals Reaches ERISA Class Action Settlement
- How Biden's First 100 Days Will Affect Gov't Contractors
- Justices Must Resolve Off-Label Drug Warning Predicament
- Cooley-Led Construction Software, Biotech Firms Prep IPOs
- Make Profitability Management Part Of Your Law Firm Culture
- Full Fed. Circ. Won't Review Becton's Wins On Drug Dosing IP
- FDA Dr. Says Stem Cell Clinics' Study 'Just A Bunch Of Words'
- Investors, CBD Pharma Co. Reach Deal Over Clinical Trial Suit
- With US On Board, COVID IP Waiver Still Faces Long Road
- Pharmacies Seek Appeal On Opioid Duties In Tribal Bellwether
- Cannabis Bill Roundup: Medical Pot Advances In The South
- Fed Circ. Revives Pharmacist's Whistleblower Case
- SC County Nixes Plan To Pay Fed. Judge Cut Of Opioid Money
- Endo Wants Stay Of $2.4B Opioid Baby Trial Pending Appeals
- Medical Pot Co. Says IT Biz Faked Signature In $10M Contract
- Merck Sued Over Asthma Drug's Alleged Psychiatric Effects
- Cell Therapy, Cannabinoid Biotechs Go Public For $171M
- Health Hires: Manatt, Fenwick, Foley Hoag
- Dermatology Case Tapped As Bellwether In Generic Drug MDL
- Fed. Circ. Backs Bracco Patent Losses At ITC, PTAB
- Purdue Asks For Another Month's Hold On Opioid Suits
- UK Litigation Roundup: Here's What You Missed In London
- Clinics' Stem Cell Treatments Endanger Patients, DOJ Says
- Ex-Theranos CEO Vies To Shield Jury From Wealth, Reportage
- 4th Circ. Mulls 'Murky' Law Around Small Zetia Buyer Class
- Generic Drug Cos. Invoke FTC Restitution Limits Against AGs
- 4 Firms Steer French COVID-19 Vaccine Maker's $94M US IPO
- Nephron To Receive $7.9M To End Trade Secrets Case
- Deals Rumor Mill: IHH Healthcare, Tricor, Reebok
- Blue Cross Unit Wants To Lead If Shkreli Faces New Suits
- 10x Launches Patent Suit Against NanoString
- 1st Circ. Hints Insys Execs' Convictions Will Stand
- Skin Care Co. Sued Over 'Mineral-Based' Sunscreen Labeling
- Drafting Clearer Patent Claims After Fed. Circ. L'Oreal Ruling
- Quest Pharmaceuticals Loses In Opioid Liability Coverage Suit
- Insurer Says It Needn't Cover Massage Oil Class Action
- 4 Trends In Discoverability Of Litigation Funding Documents
- Ex-Theranos CEO Blasts Government's Expert Witness Plan
- Opioid Crisis Is In Hospital's Front Yard, Doctor Testifies
- Generic-Drug Makers Knock States' Objection To Sanctions
- Pharma Co. Says €140M Award Suit Doesn't Belong In Mass.
- 11th Circ. Urged To Reverse Roundup Failure-To-Warn Ruling
- Judge Seeks Teva's Take On Morgan Lewis Conflict Claim
- Full 5th Circ. Redo Sought In Sanofi Chemo Hair Loss Suit
- Quest Can't Ditch ERISA Class Action Over 401(k) Investments
- Blackstone Exec Fearful Of A 'Torrent Of Economic Activity'
- Allergan Can't Escape NJ Defective Breast Implant Claims
- Chickasaw Nation Says CVS Misframes Drug Repayment Suit
- High Court's AMG Ruling Could Hinder FDA Enforcement
- Expect Increasing Scrutiny Of Wage-Fixing, No-Poach Deals
- Pfizer Loses Bid To Toss COVID-19 Vaccine IP Case
- W.Va. Consumer Law Changes Offer Help For Finance Cos.
- Biden Administration Backs IP Waiver On COVID-19 Vaccines
- Keep Junk Science Away From Juries
- Bio-Rad Ruling Highlights IP Assignment Clause Limits
- MiMedx Slams Quinn Emanuel Fees As 2 Other Firms Settle
- Buchanan Ingersoll Adds Former FDA Atty, Director
- Ex-Theranos CEO's Defense Emerges In Pre-Trial Battle
- 'Gateway Effect' Is Instant Flashpoint In Opioid MDL's 1st Trial
- 2 Firms Edge Out Peers As IPO Market Endures SPAC Slump
- Mass. AG Presses Pharmacies On Vaccine Patient Data Use
- Defunct Wholesaler Fights Renewed DQ Bid In Suboxone Case
- Real Estate Cos. More Optimistic Amid Vaccine Rollout
- Sanofi Wins $17.2M Fees, Expenses After Ditching FCA Suit
- Merck Unit Fined €7.5M For Hiding Project In EU M&A Review
- Cannabis Legalization's Effects On Insurance Industry
- 4th Circ. Says Va. County Opioid Claims Belong In Fed. Court
- Coronavirus Regulations: A State-By-State Week In Review
- 7 Lessons For Young Lawyers Starting Their Careers
- Teva Kicks Off Trial To Revoke Bayer's Cancer Drug Patent
- McKesson Wants Quick Win In Opioid Suit Coverage Battle
- Biden's HHS To Cover COVID Vaccine Administration Costs
- Opioid Reps Taught To Ease Doctors' Doubts, Witness Says
- Neal Gerber Nabs Green Griffith Patent Pro
- Sanofi Misled Buyers About Pain Relief Patches, Suit Says
- More Suits Allege Herbicide Paraquat Causes Parkinson's
- CBD Co. Zynerba, Investors Seek OK For $4M Settlement Deal
- Surgeon's Alleged Scheme Brings $33M In DOJ Settlements
- Global E-Commerce Firm Leads Quartet Of IPO Launches
- Bayer Wants To Shake Off Flea & Tick Drugs Antitrust Suit
- Bay Area Life Sciences Campus Snags $400M Loan
- Feds Want Harsher Prison Terms In Meningitis Outbreak Case
- At W.Va. Opioid Trial, Drug Cos. Battle 'Occam's Razor'
- Drug Developer Roivant Hits $7.3B Valuation In SPAC Merger